Marcsa Boglárka, Dénes Réka, Vörös Krisztina, Rácz Gergely, Sasvári-Székely Mária, Rónai Zsolt, Törő Klára, Keszler Gergely
Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest, Hungary.
1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
PLoS One. 2015 Jul 6;10(7):e0132137. doi: 10.1371/journal.pone.0132137. eCollection 2015.
Cardiac death remains one of the leading causes of mortality worldwide. Recent research has shed light on pathophysiological mechanisms underlying cardiac death, and several genetic variants in novel candidate genes have been identified as risk factors. However, the vast majority of studies performed so far investigated genetic associations with specific forms of cardiac death only (sudden, arrhythmogenic, ischemic etc.). The aim of the present investigation was to find a genetic marker that can be used as a general, powerful predictor of cardiac death risk. To this end, a case-control association study was performed on a heterogeneous cohort of cardiac death victims (n=360) and age-matched controls (n=300). Five single nucleotide polymorphisms (SNPs) from five candidate genes (beta2 adrenergic receptor, nitric oxide synthase 1 adaptor protein, ryanodine receptor 2, sodium channel type V alpha subunit and transforming growth factor-beta receptor 2) that had previously been shown to associate with certain forms of cardiac death were genotyped using sequence-specific real-time PCR probes. Logistic regression analysis revealed that the CC genotype of the rs11720524 polymorphism in the SCN5A gene encoding a subunit of the cardiac voltage-gated sodium channel occurred more frequently in the highly heterogeneous cardiac death cohort compared to the control population (p=0.019, odds ratio: 1.351). A detailed subgroup analysis uncovered that this effect was due to an association of this variant with cardiac death in chronic ischemic heart disease (p=0.012, odds ratio = 1.455). None of the other investigated polymorphisms showed association with cardiac death in this context. In conclusion, our results shed light on the role of this non-coding polymorphism in cardiac death in ischemic cardiomyopathy. Functional studies are needed to explore the pathophysiological background of this association.
心脏性死亡仍然是全球主要的死亡原因之一。最近的研究揭示了心脏性死亡背后的病理生理机制,并且已确定一些新候选基因中的遗传变异为危险因素。然而,迄今为止进行的绝大多数研究仅调查了与特定形式的心脏性死亡(猝死、致心律失常性、缺血性等)的遗传关联。本研究的目的是找到一种可作为心脏性死亡风险通用且强大预测指标的遗传标记物。为此,对一组异质性的心脏性死亡受害者(n = 360)和年龄匹配的对照组(n = 300)进行了病例对照关联研究。使用序列特异性实时PCR探针,对先前已显示与某些形式的心脏性死亡相关的五个候选基因(β2肾上腺素能受体、一氧化氮合酶1衔接蛋白、兰尼碱受体2、V型钠通道α亚基和转化生长因子-β受体2)中的五个单核苷酸多态性(SNP)进行基因分型。逻辑回归分析显示,与对照组相比,编码心脏电压门控钠通道一个亚基的SCN5A基因中rs11720524多态性的CC基因型在高度异质性的心脏性死亡队列中出现的频率更高(p = 0.019,优势比:1.351)。详细的亚组分析发现,这种效应是由于该变异与慢性缺血性心脏病中的心脏性死亡相关(p = 0.012,优势比 = 1.455)。在这种情况下,其他研究的多态性均未显示与心脏性死亡相关。总之,我们的结果揭示了这种非编码多态性在缺血性心肌病心脏性死亡中的作用。需要进行功能研究以探索这种关联的病理生理背景。